Cardiology

Top Story

Trial of DCB, atherectomy in patients with calcified femoropopliteal lesions launched

July 30, 2016

Medtronic and VIVA Physicians announced the enrollment of the first patient in the REALITY study of patients with severely calcified lesions in the femoropopliteal artery.

The trial will gauge outcomes for patients with significantly calcified and symptomatic femoropopliteal peripheral artery disease following adjunctive use of directional atherectomy (TurboHawk, Medtronic) and a drug-coated balloon (IN.PACT Admiral, Medtronic), according to a press release issued by Medtronic.

In the Journals

One hour of physical activity offsets increased risk of death from sitting

July 29, 2016
About 60 to 75 minutes of moderate intensity physical activity negated the increased risk for death associated with sitting for 8 hours each day, according to findings…
In the Journals

TINSAL-CVD: Salsalate fails to reduce progression of noncalcified coronary plaque volume

July 29, 2016
Adding salsalate to current therapies for CHD does not reduce the progression of noncalcified coronary plaque volume in overweight and obese patients using statins…
In the Journals

Procedure selection after stroke varies by race

July 29, 2016
Among patients with stroke, those of a minority race had higher odds than white patients of receiving life-sustaining procedures, but the reverse was true for carotid…
Meeting News CoverageVideo

VIDEO: EMPA-REG, LEADER trial results produce ‘exciting time’ for diabetes care

July 29, 2016
NEW ORLEANS — The results of the EMPA-REG Outcome study and the LEADER trial have expanded physicians’ armamentariums to be able to decrease patients with…
More News Headlines »
CME

The Patient with CAD Who Develops Peripheral Arterial Disease

No commercial support for this activity.

The prevention of cardiovascular disease (CVD) is crucial in light of its associated mortality, morbidity, and economic…
More »
Video
Meeting News Coverage

VIDEO: Results of LEADER trial provide “robust demonstration” of cardiovascular event reduction in high-risk type 2 diabetes

July 1, 2016
More »
Featured
AAHFN 2016

AAHFN 2016

Video
Meeting News Coverage

VIDEO: EMPA-REG, LEADER trial results produce ‘exciting time’ for diabetes care

July 29, 2016
More »
morganatic-roan
morganatic-roan